Strategic Positioning Ion Torrent's PostLight sequencing provides a non optical workflow and a distinct value proposition in the genomics market. This differentiation can attract labs and biotech startups seeking alternative sequencing platforms, especially for precision medicine projects. Use this angle to initiate conversations with mid sized labs, contract research organizations, and service providers looking to diversify their toolkits.

Partnership Potential Past acquisition activity hints at the viability of partnerships to extend reach. Build channel partnerships with genomics labs, CROs, clinical testing providers, and integrators to co-sell and co-market sequencing capabilities, accelerating access to customers and validation of the platform.

Consumables Alignment Explore opportunities to supply consumables and support services that align with Ion Torrent workflows, including reagents and ongoing maintenance. A bundled offering with confirmed uptime and support could reduce install risk for labs evaluating new sequencing approaches.

Informatics Advantage Capitalize on the direct bridge between chemistry and digital data by offering integrated analytics, variant interpretation pipelines, and secure data management. A turnkey data solution could improve time-to-insight and create cross-sell opportunities with customers needing end-to-end sequencing workflows.

Go To Market With limited internal resources, position Ion Torrent as a managed services or outsourcing option to reduce customer setup burden. Create flexible engagement models and targeted outreach to mid sized academic labs, medtech startups, and regional sequencing providers to de-risk adoption and drive trials.